3
Announcements
Trials
Browse
Landscape
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Polycythemia Vera
2
Myeloproliferative Disorders
2
Lung Neoplasms
2
Tuberous Sclerosis
1
Smoking
1
Renal Insufficiency, Chronic
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Multiple Sclerosis
1
Lymphangioleiomyomatosis
1
Liver Cirrhosis, Biliary
1
Lip Neoplasms
1
Irritable Bowel Syndrome
1
Inflammatory Bowel Diseases
1
Hepatitis
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Gastritis
1
Fibrosis
1
Exocrine Pancreatic Insufficiency
1
Endocrine Gland Neoplasms
1
Dyslipidemias
1
Diabetes Mellitus
1
Cystic Fibrosis
1
Crohn Disease
1
Chronic Pain
1
Chronic Disease
1
Interventions
Bismuth
3
Tetracycline
2
Esomeprazole
2
Clarithromycin
2
Amoxicillin
2
Surveys and Questionnaires
1
Physical Examination
1
Phlebotomy
1
Minocycline
1
Gastroscopy
1
Furazolidone
1
Endoscopy, Digestive System
1
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastritis
×
Phlebotomy
×
1 year
×
Clear all
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled